Rang	Name	Position
1	Mr. Mark L. Baum J.D.	CEO, Chairman of the Board & Founder
2	Mr. Andrew R. Boll C.F.A., C.M.A.	President, CFO & Chief Accounting Officer
3	Dr. Amir W. Shojaei Ph.D., Pharm.D.	Chief Scientific Officer
4	Mr. Francis W. Mullery	President & CEO of Harrow's ImprimisRx Division
5	Mr. Michael D. Biega	Vice President of Investor Relations & Communications
6	Mr. Brett A. Burrell	Vice President of Legal & Compliance
7	Ms. Kim Barratt	Chief Talent Officer
8	Dr. Mark A. Mannebach Ph.D., R.Ph.	Head of Regulatory Affairs & Pharmacovigilance
9	Dr. Prashanth S. Annavajjhala	Chief of Staff
10	Mr. Patrick W. Sullivan	Chief Commercial Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	6,81%	0,09 Mrd. USD
2	Opaleye Management Inc	6,40%	0,08 Mrd. USD
3	Private Capital Management, LLC	4,26%	0,06 Mrd. USD
4	Vanguard Capital Management, LLC	3,74%	0,05 Mrd. USD
5	Deep Track Capital, LP	2,58%	0,03 Mrd. USD
6	State Street Corp	2,28%	0,03 Mrd. USD
7	Geode Capital Management, LLC	2,27%	0,03 Mrd. USD
8	Dimensional Fund Advisors, Inc.	1,78%	0,02 Mrd. USD
9	Marshall Wace Asset Management Ltd	1,72%	0,02 Mrd. USD
10	Ikarian Capital, LLC	1,45%	0,02 Mrd. USD
11	Susquehanna International Group, LLP	1,22%	0,02 Mrd. USD
12	Rice Hall James & Associates, LLC	1,03%	0,01 Mrd. USD
13	Citadel Advisors Llc	0,96%	0,01 Mrd. USD
14	The Goldman Sachs Group Inc	0,91%	0,01 Mrd. USD
15	Northern Trust Corp	0,79%	0,01 Mrd. USD
16	Vanguard Portfolio Management, LLC	0,77%	0,01 Mrd. USD
17	Charles Schwab Investment Management Inc	0,72%	0,01 Mrd. USD
18	New York State Common Retirement Fund	0,72%	0,01 Mrd. USD
19	Stifel Financial Corp	0,63%	0,01 Mrd. USD
20	Vanguard Fiduciary Trust Co	0,61%	0,01 Mrd. USD